Veeva Systems (VEEV) shares ended the last trading session 5.2% higher at $235. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 6.3% gain over the past four weeks.The sharp upsurge in VEEV shares can be attributed to positive market sentiment surrounding its strong recent financial performance. The company has shown impressive growth, with a year-to-date returns of 22%. Investors seem to be optimistic about Veeva S ...

DEERFIELD, Ill. and PLEASANTON, Calif., Oct. 24, 2024 /PRNewswire/ -- Walgreens (Nasdaq: WBA), an integrated healthcare, pharmacy, and retail leader, and Veeva Systems (NYSE: VEEV) a leading provider of software, data, and services for the life sciences industry, today announced a long-term partnership to help life sciences companies improve patient outcomes.The partnership enriches Veeva Data Cloud products and allows Walgreens to better serve life sciences through access to Veeva Data Cloud and Veeva Clin ...

Event Details - Veeva Systems will host its 2024 Investor Day virtually on Thursday, November 7, 2024, starting at 1:30 p.m. PT and concluding at approximately 3:30 p.m. PT [1] - The event will be broadcast live on the company's investor relations website, ir.veeva.com, with an archived webcast available post-event [1] - Online event registration is accessible via the company's investor relations website or a direct link provided [1] Company Overview - Veeva Systems is the global leader in cloud software for the life sciences industry, serving over 1,000 customers, including major pharmaceutical companies and emerging biotechs [2] - The company is a Public Benefit Corporation, committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves [2] Investor Relations - Veeva uses its ir.veeva.com website to disclose material non-public information, announce upcoming investor conferences, and comply with Regulation FD disclosure obligations [3] - Investors are advised to monitor the investor relations website in addition to press releases, SEC filings, and public conference calls and webcasts [3] Contact Information - Investor Relations Contact: Gunnar Hansen, Veeva Systems Inc., 267-460-5839, [email protected] [3] - Media Contact: Maria Scurry, Veeva Systems Inc., 781-366-7617, [email protected] [3]

Veeva Systems (VEEV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares of this provider of cloud-based software services for the life sciences industry have returned -4.3% over the past month versus the Zacks S&P 500 composite's +1.3% change. The Zacks Internet - Software industry, to which Veeva belongs, has gained 5.6% over this period. Now the key question is: Where cou ...

More than 125 medtech customers use Veeva applications for seamless execution across product development PLEASANTON, Calif., Oct. 2, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that 18 of the top 20 medtech companies leverage Veeva Development Cloud and Veeva Commercial Cloud applications to streamline processes across the total medtech product lifecycle. Veeva MedTech enables more than 125 customers with deep industry expertise and technology from ideation to commercialization. With an ...

A month has gone by since the last earnings report for Veeva Systems (VEEV) . Shares have lost about 3.5% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or is Veeva due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. Veeva Systems Q2 Earnings & Revenues Beat, Operating Ma ...

Veeva Systems Inc. (VEEV) announced the expansion of Veeva Vault QMS yesterday. The expansion is expected to add new capabilities to manage MedTech field actions and product recalls. The latest availability of expanded features is expected to significantly boost Veeva Systems' Vault Quality suite and solidify its foothold in the niche space. Likely Trend of VEEV Stock Following the News Following the announcement on Sept. 24, 2024, shares of the company moved nearly 1.5% south to $207.91 at yesterday's clos ...

Veeva Systems Inc. (VEEV) is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by a solid second-quarter fiscal 2025 performance and strategic deals, is expected to contribute further. Stiff competition and rising operational costs persist. This Zacks Rank #3 (Hold) company's shares have gained 8% in the year-to-date period compared with 20.9% growth of the industry. The S&P 500 Composite has risen 20.2% during the said time frame. The renowned provid ...

Core Insights - Veeva Systems has expanded its Veeva Vault QMS to enhance management of medtech field actions and product recalls, improving oversight, timeliness, and accuracy throughout the process [1][2][3] Group 1: New Capabilities - The new features in Veeva Vault QMS will facilitate the entire field action process, including issue identification, evaluation, planning, execution, and monitoring through to closure [1] - The integration of field actions and recall management with adjacent quality processes such as complaint handling and quality risk management reduces manual transcription needs, thereby enhancing efficiency [2] Group 2: Industry Collaboration - Veeva has collaborated closely with industry partners like Teleflex to develop these capabilities, aiming to streamline processes and improve customer service [2] - The company emphasizes the importance of understanding industry needs to deliver solutions that enhance agility in critical processes related to product quality and patient safety [3] Group 3: Company Overview - Veeva Systems is recognized as a global leader in cloud software for the life sciences sector, serving over 1,000 customers, including major biopharmaceutical companies and emerging biotechs [4] - As a Public Benefit Corporation, Veeva is dedicated to balancing the interests of all stakeholders, including customers, employees, and shareholders [4]

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor. It also includes access to the Zacks Style Scores. What are the Zacks Style Scores? The Z ...